Pfizer's COVID antiviral Paxlovid gains full US approval

Indonesia Berita Berita

Pfizer's COVID antiviral Paxlovid gains full US approval
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 YahooNews
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 59%

The approval for the pill, initially authorized in late 2021 for emergency use in the U.S., will provide doctors with more flexibility in prescribing it to adults with severe COVID-19 symptoms who are at at risk of progression to severe disease.

-The U.S. Food and Drug Administration on Thursday granted full approval to Pfizer's oral antiviral COVID-19 treatment Paxlovid, clearing the way for the drugmaker to sell it at market rates once U.S. government supplies dwindle.

Paxlovid, taken for five days beginning shortly after onset of symptoms, was one of the few treatments launched by drugmakers during the pandemic to show a significant reduction in hospitalizations and deaths from COVID, although the benefit was mostly observed in unvaccinated and other higher-risk people.

As of May 21, around 14 million treatment courses had been distributed of which over 9 million had been administered, according to federal data. Pfizer received a once-in-a-lifetime cash windfall from sales of its COVID vaccine and treatment. It sold around $18.9 billion of Paxlovid last year and has forecast sales of about $8 billion for 2023.The full approval comes two weeks after the U.S. ended the public health emergency status for COVID-19, which has caused about 1.1 million deaths nationwide, according to government estimates.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

YahooNews /  🏆 380. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Paxlovid, Pfizer's COVID-19 pill, gets full FDA approvalPaxlovid, Pfizer's COVID-19 pill, gets full FDA approvalU.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid.
Baca lebih lajut »

Pfizer's COVID antiviral Paxlovid gains full US approvalPfizer's COVID antiviral Paxlovid gains full US approvalThe U.S. Food and Drug Administration on Thursday granted full approval to Pfizer's oral antiviral COVID-19 treatment Paxlovid, clearing the way for the drugmaker to sell it at market rates once U.S. government supplies dwindle.
Baca lebih lajut »

Pfizer's Paxlovid still free, for now, after FDA grants full approval to COVID drugPfizer's Paxlovid still free, for now, after FDA grants full approval to COVID drugThe Biden administration will continue to manage the distribution of free courses of Pfizer's Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the FDA granted Pfizer full approval Thursday to market the pills.
Baca lebih lajut »

COVID-19 pill Paxlovid gets full FDA approval after over a year of emergency useCOVID-19 pill Paxlovid gets full FDA approval after over a year of emergency useThursday’s action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely.
Baca lebih lajut »

COVID pill Paxlovid gets full FDA approval after more than a year of emergency useCOVID pill Paxlovid gets full FDA approval after more than a year of emergency useMore than 14,000 new COVID-19 cases were reported each week last month, although most U.S. cases are no longer reported to health authorities.
Baca lebih lajut »

Grand jury indicts New Jersey police officer on manslaughter charge in fatal 2021 shootingGrand jury indicts New Jersey police officer on manslaughter charge in fatal 2021 shootingA Mantua Township, N.J., police officer was indicted by a grand jury for manslaughter in the fatal shooting of a civilian in September 2021.
Baca lebih lajut »



Render Time: 2025-02-27 11:40:55